Equity Overview
Price & Market Data
Price: $13.99
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $217,054,384
Daily Volume: 0
Performance Metrics
1 Week: 3.25%
1 Month: -5.60%
3 Months: -4.05%
6 Months: -4.05%
1 Year: -4.05%
YTD: -5.15%
Company Details
Employees: 511
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.